Article Versions Notes

D’Ambrosio M, Bigagli E, Cinci L, Gencarelli M, Chioccioli S, Biondi N, Rodolfi L, Niccolai A, Zambelli F, Laurino A, et al. Tisochrysis lutea F&M-M36 Mitigates Risk Factors of Metabolic Syndrome and Promotes Visceral Fat Browning through β3-Adrenergic Receptor/UCP1 Signaling. Marine Drugs. 2023; 21(5):303. https://doi.org/10.3390/md21050303

D’Ambrosio, Mario, Elisabetta Bigagli, Lorenzo Cinci, Manuela Gencarelli, Sofia Chioccioli, Natascia Biondi, Liliana Rodolfi, Alberto Niccolai, Francesca Zambelli, Annunziatina Laurino, and et al. 2023. "Tisochrysis lutea F&M-M36 Mitigates Risk Factors of Metabolic Syndrome and Promotes Visceral Fat Browning through β3-Adrenergic Receptor/UCP1 Signaling" Marine Drugs 21, no. 5: 303. https://doi.org/10.3390/md21050303

D’Ambrosio, M., Bigagli, E., Cinci, L., Gencarelli, M., Chioccioli, S., Biondi, N., Rodolfi, L., Niccolai, A., Zambelli, F., Laurino, A., Raimondi, L., Tredici, M. R., & Luceri, C. (2023). Tisochrysis lutea F&M-M36 Mitigates Risk Factors of Metabolic Syndrome and Promotes Visceral Fat Browning through β3-Adrenergic Receptor/UCP1 Signaling. Marine Drugs, 21(5), 303. https://doi.org/10.3390/md21050303